News
From our correspondent Perry Lesion...| Smith & Nephew agrees to partner with Gunze, Japan. |
|
Smith & Nephew have agreed to an exclusive distributorship of PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand. PELNAC is a collagen matrix with silicone top layer for use on full thickness injuries such as burns and trauma. The full story may be found at PELNAC
Fri 25 Dec 2009 by Perry Lesion |
| Smith & Nephew completes Nucryst buyout |
|
Smith & Nephew (Wound Management Division) completed its USD 21 million deal for Nucryst Pharmaceuticals Corp. The nanocrystalline silver technology used in the Acticoat wound dressing together with the related intelectual property and manufacturing assets will be absorbed into the S&N fold. Read more at Nucryst buyout
Thu 24 Dec 2009 by Perry Lesion |
| Trends in Wound Care vol V |
|
The fifth volume in this popular series of Trends in Wound Care is edited by Keith F Cutting and is now available from Quay Books. The Foreword written by Prof R White (University of Worcester) includes the statement - This highly reputable source of up-to-date monographs has become a standard text for those seeking to keep in touch with key areas of clinical and scientific research. Copies may be ordered via the Quay Books website at Trends V. Happy Reading.
Mon 23 Mar 2009 by Perry Lesion |
| Unomedical head towards Aspen |
|
ConvaTec has announced the divestiture of Unomedical wound care to Aspen Surgical Products Holding, Inc. Aspen are in turn owned by private equity firm RoundTable Healthcare Partners. If you want to read more take a look at ConvaTec divests.
Sun 01 Mar 2009 by Perry Lesion |
| Smith and Nephew and NPWT - new device |
|
First of all it was Blue Sky that morphed into Vista and now we have RENASYS EZ. Smith and Nephew have launched a new NPWT device at American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas. You can read more at RENASYS EZ
Wed 25 Feb 2009 by Perry Lesion |
| Baby boomers assist Smith and Nephew |
|
Smith and Nephew appear to be benefiting from the aging joints of Baby Boomers and this has combined with a strong demand for wound management products. Read it all at Ride the recession.
Sun 15 Feb 2009 by Perry Lesion |
| KCI patents upheld |
|
Two key patents have been upheld by a federal court. The market reacted favorably to this news even though the 2006 court decision partially in favor of competitor Blue Sky was not overturned. Read more at Blue Skies for KCI.
Wed 04 Feb 2009 by Perry Lesion |
| KCI profits down |
|
KCI report a 21.7 percent drop in profit from 12 months ago. This is blamed on restructuring costs and the acquisition of LifeCell. None the less revenue was up 14 percent to $492.5 million. Read the full story at KCI profit drop. Wed 28 Jan 2009 by Perry Lesion |
| The good news and the bad news |
|
ConvaTec have announced signing of a long-term global agreement with Boehringer Technologies to market and distribute Boehringer's Engenex(R) Negative Pressure Wound Therapy System. The press release may be viewed at ConvaTec and Boehringer. It seems that KCI do not like another threat looming on the NPWT horizon and have filed a patent infringement suit against ConvaTec and Boehringer. C'est la vie, c'est la guerre
Fri 19 Dec 2008 by Perry Lesion |
| The end of an era! |
|
The sale of J and J wound care division ETHICON has been completed. The new owners One Equity Partners are now in the driving seat. Read on...One Equity Partners
Tue 02 Dec 2008 by Perry Lesion |